thursday

18

May
2017

PANEL: Financing in post-truth times - moderated by Gert Vanhees, Partner, Deloitte

View full programme

Dara Henry - Fund Director, Immunology Innovation Fund, GSK

Short description of the presentation:

The presentation will explain the purpose and background to the Immunology Innovation Fund, and how it aligns with GSK’s Immunology Network. It will also describe how the fund approaches sourcing innovation that is strategically aligned with GSK R&D.

Biography of the speaker:

Dara is currently director of the Immunology Innovation Fund at GSK, which identifies and evaluates areas of breaking science, aligned with the company’s R&D strategy, then incubates projects through to a key inflection point. Prior to this, Dara was portfolio director for GSK’s pipeline in Immuno-Inflammation, overseeing a wide range of projects from discovery and early clinical through to late stage development. He was also a director in GSK’s R&D Strategy Group (internal consulting arm), leading a number of high profile business projects. Prior to GSK, Dara was an equity research analyst at Credit Suisse covering European biotech in a top ranked team. He holds a PhD in organic chemistry from Cambridge University, where he also completed his MSci in Natural Sciences.

PLATINUM SPONSORS

No Platinum sponsor yet.
Click here and become the first Platinum sponsor.

Gold sponsors

Silver sponsors